Resumo

CHAVES SOLANO, Luis Alejandro  e  BOLANOS RODRIGUEZ, Hernán. Cardiovascular Safety of Oral Antidiabetics. Rev. costarric. cardiol [online]. 2017, vol.19, n.1-2, pp.13-17. ISSN 1409-4142.

Cardiovascular Safety of Oral Antidiabetics

Diabetes Mellitus type 2 (DM-2) is an equivalent of cardiovascular risk. There is a wide variety of drugs for the glycemic control in patients with DM-2, which have differences in their cardiovascular profile, some have shown a benefit in reducing the risk of cardiovascular events, others have a neutral effect, and in the case of other drugs such as sulfonylurea and thiazolidinedione, there are doubts about their cardiovascular safety. Being DM-2 an equivalent of coronary risk, it is essential to consider the cardiovascular risk profile of these medicines when starting any of these drugs and not only their effectiveness in controlling glycaemia levels. The objective of this review is to comment on the most recent studies evaluating cardiovascular risk with the use of different oral antidiabetics.

Palavras-chave : diabetes mellitus type 2; cardiovascular risk; glycemia; antidiabetic.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )